Announced Mon, 6 Jul · 17:47 IST
Natco Pharma designates two senior officials in R&D roles
Management Changes View source PDF
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.8%1-day move
₹931.05
prior close
₹934.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.9-1.0-0.1+3.8+3.3+5.6+5.2+4.4+3.7————
Up moveDown movePending
AI summary
Natco Pharma has designated two officials in senior research and development roles effective 6 July 2026. Gnanadeva Chalapathy Gudipati has been named Senior Vice President of Analytical R&D, having been with the company since 2017. Madhava Rao Karicherla has been named Vice President of Formulation R&D for the Pharma Division at the Kothur unit, joining in November 2024 with over 20 years of industry experience. Both appointments are per company policy.
Likely market impact
Internal senior management elevations. No material impact on shareholders or operations expected.